Stem cell therapy for Lupus (SLE) — for patients from Israel

If you are researching Lupus (SLE) treatment from Israel, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €10,000–€40,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.

How Lupus (SLE) is treated

Lupus (systemic lupus erythematosus, SLE) is an autoimmune disease in which the body's immune system mistakenly attacks its own tissues, particularly affecting joints, skin, kidneys, and the nervous system. The condition arises when B cells and T cells lose tolerance to self-antigens, producing damaging antibodies and inflammatory cytokines. Placental mesenchymal stem cells show promise because they release immunomodulatory factors—interleukins, soluble HLA-G, and exosomes containing regulatory microRNAs—that rebalance Th17 and regulatory T-cell populations. Early-stage clinical research (47 registered trials, 6 currently recruiting) suggests this approach may reduce disease activity scores and improve organ function in selected patients, though long-term remission rates remain under investigation. It is delivered under a physician-led protocol and designed to complement your existing care.

Your cost from Israel

Cost ranges are indicative market figures for planning, not quotes.